<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The specific humoral response against <z:chebi fb="1" ids="15841">polypeptide</z:chebi> components of Epstein-Barr virus (EBV), the induced early diffuse antigen (EA-D), in patients with <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue diseases</z:e>, including <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) and <z:e sem="disease" ids="C0026272" disease_type="Disease or Syndrome" abbrv="MCTD">mixed connective tissue disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCTD</z:e>), was investigated by using the immunoblotting technique </plain></SENT>
<SENT sid="1" pm="."><plain>The EA(D)-positive sera from patients with <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">infectious mononucleosis</z:e> (IM), nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp> (NPC), immunocompromised patients (renal transplant recipients and patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>) as well as the EA(D)-negative sera from patients with Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and from clinically healthy subjects served as controls </plain></SENT>
<SENT sid="2" pm="."><plain>Seven major antigenic <z:chebi fb="1" ids="15841">polypeptides</z:chebi> with molecular weights of 33 kDa, 35 kDa, 52 kDa, 54 kDa, 56 kDa, 58 kDa, and 134 kDa were detected reproducibly by the EA(D)-positive reference sera and, in particular, by each of the NPC sera tested </plain></SENT>
<SENT sid="3" pm="."><plain>The EA(D)-positive sera from the other groups showed various combinations of detection patterns and few samples reacted with <z:hpo ids='HP_0000001'>all</z:hpo> the major EA(D) <z:chebi fb="1" ids="15841">polypeptides</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Seventy-three percent of sera from SLE and 47% of sera from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCTD</z:e> were found to react with EA(D) </plain></SENT>
<SENT sid="5" pm="."><plain>Sixty-one percent of sera from SLE vs. 5% from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCTD</z:e> detected <z:hpo ids='HP_0000001'>all</z:hpo> the EA(D) <z:chebi fb="1" ids="15841">polypeptides</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>These results could either reflect perturbations of the immune response linked to the <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo> or suggest a possible pathogenic role of EBV </plain></SENT>
</text></document>